Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Bader Al-Rawahi

Biographic Data

ID7750139
NAMEBader Al-Rawahi
GIVEN NAMESBader
FAMILY NAMEAl-Rawahi
SIGNATUREAL-RAWAHI B
AFFILIATIONSMinistry of Health
VERIFIEDNo
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Timely vaccination with valid doses in a high coverage country, Oman

    Open Access•K Prakash, Prakash KP et al.•ARTICLE•BMC Public Health•2025

    Oman achieves high vaccination coverage; however, a noteworthy number of children receive invalid doses. This highlights the urgent need to educate parents and healthcare providers on timely administration of valid doses. Assessing mild illnesses and promptly administering vaccinations can improve complete vaccination rates with valid doses

  • Treatment outcomes 12 months after antiretroviral therapy initiation in Oman

    Ali Elgalib, Samir Shah et al.•ARTICLE•AIDS Care•2023

    We used routinely collected programme data on people living with HIV in Oman who started ART in 2014-2018 to assess retention on ART, viral suppression, attrition (mortality or loss to follow-up [LTFU]) and treatment failure (attrition or HIV viral load of > 1000 copies/mL) 12 months after antiretroviral therapy (ART) initiation. We identified 726 patients; 72% were male. Overall, 12 months retention on ART and viral suppression (intention-to-tre…

  • Retention in HIV care and factors associated with loss to follow-up in Oman

    Ali Elgalib, Samir Shah et al.•ARTICLE•AIDS Care•2022

    We conducted a cross-sectional analysis to determine the rate of retention in HIV care and the factors associated with loss to follow-up (LTFU) among Omani adults living with HIV who were linked to care as of 31 December 2019. Patients (n = 1610) were identified from a central national HIV surveillance dataset. The majority (68.3%) of patients were male, and the median age was 39 years (IQR, 31–48 years). A total of 1480 patient (91.9%) were reta…

  • Predictors of late presentation and advanced HIV disease among people living with HIV in Oman (2000–2019)

    Open Access•Ali Elgalib, Samir Shah et al.•ARTICLE•BMC Public Health•2021

    This analysis indicates that a significant proportion of new HIV cases in Oman continue to present late. This study identified patient subgroups at greatest risk of late HIV diagnosis such as men and older people. Targeted interventions and greater efforts to scale up HIV testing services in Oman are needed

No prominent works on this page.

  • Predictors of late presentation and advanced HIV disease among people living with HIV in Oman (2000–2019)

    Open Access•Ali Elgalib, Samir Shah et al.•ARTICLE•BMC Public Health•2021

    This analysis indicates that a significant proportion of new HIV cases in Oman continue to present late. This study identified patient subgroups at greatest risk of late HIV diagnosis such as men and older people. Targeted interventions and greater efforts to scale up HIV testing services in Oman are needed

  • Retention in HIV care and factors associated with loss to follow-up in Oman

    Ali Elgalib, Samir Shah et al.•ARTICLE•AIDS Care•2022

    We conducted a cross-sectional analysis to determine the rate of retention in HIV care and the factors associated with loss to follow-up (LTFU) among Omani adults living with HIV who were linked to care as of 31 December 2019. Patients (n = 1610) were identified from a central national HIV surveillance dataset. The majority (68.3%) of patients were male, and the median age was 39 years (IQR, 31–48 years). A total of 1480 patient (91.9%) were reta…

  • Treatment outcomes 12 months after antiretroviral therapy initiation in Oman

    Ali Elgalib, Samir Shah et al.•ARTICLE•AIDS Care•2023

    We used routinely collected programme data on people living with HIV in Oman who started ART in 2014-2018 to assess retention on ART, viral suppression, attrition (mortality or loss to follow-up [LTFU]) and treatment failure (attrition or HIV viral load of > 1000 copies/mL) 12 months after antiretroviral therapy (ART) initiation. We identified 726 patients; 72% were male. Overall, 12 months retention on ART and viral suppression (intention-to-tre…

  • Timely vaccination with valid doses in a high coverage country, Oman

    Open Access•K Prakash, Prakash KP et al.•ARTICLE•BMC Public Health•2025

    Oman achieves high vaccination coverage; however, a noteworthy number of children receive invalid doses. This highlights the urgent need to educate parents and healthcare providers on timely administration of valid doses. Assessing mild illnesses and promptly administering vaccinations can improve complete vaccination rates with valid doses

Internal Medicine (4 works) · Medicine (4 works) · Family medicine (3 works) · HIV, Drug Use, Sexual Risk (3 works) · HIV/AIDS Research and Interventions (3 works) · Antiretroviral therapy (2 works) · Antiretroviral treatment (2 works) · Biostatistics (2 works) · Demography (2 works) · Epidemiology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae